AIC
MRNA icon

Archer Investment Corporation’s Moderna MRNA Stock Holding History

Archer Investment Corporation’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4K Hold
520
– – 0.01% 623
2025
Q4 		$15.3K Hold
520
– – ﹤0.01% 644
2025
Q3 		$13.4K Buy
520
+20
+4% +$558 ﹤0.01% 678
2025
Q2 		$13.8K Hold
500
– – ﹤0.01% 654
2025
Q1 		$14.2K Hold
500
– – ﹤0.01% 631
2024
Q4 		$20.8K Hold
500
– – 0.01% 575
2024
Q3 		$33.4K Sell
500
-34
-6% -$3.12K 0.01% 491
2024
Q2 		$63.4K Hold
534
– – 0.02% 396
2024
Q1 		$56.9K Hold
534
– – 0.02% 400
2023
Q4 		$53.1K Hold
534
– – 0.02% 388
2023
Q3 		$55.2K Buy
534
+222
+71% +$24.8K 0.02% 368
2023
Q2 		$37.9K Sell
312
-188
-38% -$25.1K 0.01% 416
2023
Q1 		$76.8K Hold
500
– – 0.03% 319
2022
Q4 		$89.8K Hold
500
– – 0.03% 283
2022
Q3 		$59.1K Hold
500
– – 0.02% 306
2022
Q2 		$71.4K Hold
500
– – 0.03% 281
2022
Q1 		$86.1K Hold
500
– – 0.03% 288
2021
Q4 		$127K Hold
500
– – 0.04% 248
2021
Q3 		$192K Hold
500
– – 0.07% 215
2021
Q2 		$117K Sell
500
-917
-65% -$164K 0.05% 228
2021
Q1 		$186K Sell
1,417
-1,198
-46% -$174K 0.08% 200
2020
Q4 		$273K Buy
2,615
+1,494
+133% +$151K 0.13% 164
2020
Q3 		$79.3K Buy
1,121
+121
+12% +$8.44K 0.04% 218
2020
Q2 		$64.2K Sell
1,000
-1,000
-50% -$54.8K 0.04% 228
2020
Q1 		$60K Buy
+2,000
New +$46K 0.04% 227

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Archer Investment Corporation's MRNA Position: Q1 2026 in Review

Archer Investment Corporation held its Moderna (MRNA) position steady in Q1 2026 at 520 shares worth $26.4K. The position accounts for 0.01% of the portfolio, ranked #623.

Archer Investment Corporation first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $273K in Q4 2020. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Archer Investment Corporation held 520 shares of Moderna worth $26.4K as of Q1 2026.
  • Archer Investment Corporation left its Moderna share count unchanged in Q1 2026.
  • Moderna made up 0.01% of Archer Investment Corporation's portfolio in Q1 2026, its #623 holding.
  • Archer Investment Corporation first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • Archer Investment Corporation's Moderna position peaked at $273K in Q4 2020.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.